• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白与清道夫受体-BI结合可激活内皮型一氧化氮合酶。

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.

作者信息

Yuhanna I S, Zhu Y, Cox B E, Hahner L D, Osborne-Lawrence S, Lu P, Marcel Y L, Anderson R G, Mendelsohn M E, Hobbs H H, Shaul P W

机构信息

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Nat Med. 2001 Jul;7(7):853-7. doi: 10.1038/89986.

DOI:10.1038/89986
PMID:11433352
Abstract

Atherosclerosis is the primary cause of cardiovascular disease, and the risk for atherosclerosis is inversely proportional to circulating levels of high-density lipoprotein (HDL) cholesterol. However, the mechanisms by which HDL is atheroprotective are complex and not well understood. Here we show that HDL stimulates endothelial nitric oxide synthase (eNOS) in cultured endothelial cells. In contrast, eNOS is not activated by purified forms of the major HDL apolipoproteins ApoA-I and ApoA-II or by low-density lipoprotein. Heterologous expression experiments in Chinese hamster ovary cells reveal that scavenger receptor-BI (SR-BI) mediates the effects of HDL on the enzyme. HDL activation of eNOS is demonstrable in isolated endothelial-cell caveolae where SR-BI and eNOS are colocalized, and the response in isolated plasma membranes is blocked by antibodies to ApoA-I and SR-BI, but not by antibody to ApoA-II. HDL also enhances endothelium- and nitric-oxide-dependent relaxation in aortae from wild-type mice, but not in aortae from homozygous null SR-BI knockout mice. Thus, HDL activates eNOS via SR-BI through a process that requires ApoA-I binding. The resulting increase in nitric-oxide production might be critical to the atheroprotective properties of HDL and ApoA-I.

摘要

动脉粥样硬化是心血管疾病的主要病因,而动脉粥样硬化的风险与循环中的高密度脂蛋白(HDL)胆固醇水平呈负相关。然而,HDL具有抗动脉粥样硬化作用的机制很复杂,尚未完全明确。在此我们表明,HDL可刺激培养的内皮细胞中的内皮型一氧化氮合酶(eNOS)。相比之下,主要的HDL载脂蛋白ApoA-I和ApoA-II的纯化形式以及低密度脂蛋白均不能激活eNOS。在中国仓鼠卵巢细胞中的异源表达实验表明,清道夫受体BI(SR-BI)介导了HDL对该酶的作用。在SR-BI和eNOS共定位的分离的内皮细胞小窝中可证实HDL对eNOS的激活作用,并且分离的质膜中的反应被抗ApoA-I和SR-BI的抗体阻断,但不被抗ApoA-II的抗体阻断。HDL还可增强野生型小鼠主动脉中内皮依赖性和一氧化氮依赖性舒张,但对纯合SR-BI基因敲除小鼠的主动脉无此作用。因此,HDL通过一种需要ApoA-I结合的过程经由SR-BI激活eNOS。由此导致的一氧化氮生成增加可能对HDL和ApoA-I的抗动脉粥样硬化特性至关重要。

相似文献

1
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.高密度脂蛋白与清道夫受体-BI结合可激活内皮型一氧化氮合酶。
Nat Med. 2001 Jul;7(7):853-7. doi: 10.1038/89986.
2
The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.清道夫受体B类I型衔接蛋白PDZK1维持内皮细胞单层的完整性。
Circ Res. 2008 Feb 29;102(4):480-7. doi: 10.1161/CIRCRESAHA.107.159079. Epub 2008 Jan 3.
3
The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.人和小鼠肝脏B类I型清道夫受体(SR-BI)在低密度脂蛋白胆固醇酯选择性摄取中的作用。
Biochemistry. 2003 Jun 24;42(24):7527-38. doi: 10.1021/bi026949a.
4
Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis.高密度脂蛋白受体SR-BI对脂蛋白代谢及动脉粥样硬化的影响。
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1732-8. doi: 10.1161/01.ATV.0000091363.28501.84. Epub 2003 Aug 14.
5
HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.与高密度脂蛋白(HDL)相关的雌二醇以SR-BI依赖的方式刺激内皮型一氧化氮合酶并引起血管舒张。
J Clin Invest. 2003 May;111(10):1579-87. doi: 10.1172/JCI16777.
6
Scavenger receptor class B type I (SR-BI) and high-density lipoprotein metabolism: recent lessons from genetically manipulated mice.I型清道夫受体B类(SR-BI)与高密度脂蛋白代谢:基因工程小鼠的最新研究成果
Int J Tissue React. 2000;22(2-3):29-37.
7
A novel ligand-independent apoptotic pathway induced by scavenger receptor class B, type I and suppressed by endothelial nitric-oxide synthase and high density lipoprotein.一种由I型B类清道夫受体诱导且受内皮型一氧化氮合酶和高密度脂蛋白抑制的新型非配体依赖性凋亡途径。
J Biol Chem. 2005 May 13;280(19):19087-96. doi: 10.1074/jbc.M500944200. Epub 2005 Mar 4.
8
High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner.高密度脂蛋白与B类I型清道夫受体结合,以神经酰胺依赖性方式激活内皮型一氧化氮合酶。
J Biol Chem. 2002 Mar 29;277(13):11058-63. doi: 10.1074/jbc.M110985200. Epub 2002 Jan 15.
9
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.高密度脂蛋白受体SR-BI的过表达会改变血浆高密度脂蛋白和胆汁胆固醇水平。
Nature. 1997 May 22;387(6631):414-7. doi: 10.1038/387414a0.
10
Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models.内皮脂肪酶和B类I型清道夫受体对基因敲除小鼠模型中高密度脂蛋白代谢的差异加性效应。
Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):149-54. doi: 10.1161/01.ATV.0000150414.89591.6a. Epub 2004 Nov 11.

引用本文的文献

1
HDL attenuates Ang II-AT1R-EGFR signaling and reverses vascular remodeling in spontaneously hypertensive rats.高密度脂蛋白减轻自发性高血压大鼠的血管紧张素II - 1型血管紧张素受体 - 表皮生长因子受体信号传导并逆转血管重塑。
Front Pharmacol. 2025 Jul 29;16:1617420. doi: 10.3389/fphar.2025.1617420. eCollection 2025.
2
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome.高密度脂蛋白胆固醇与甘油三酯动态变化:代谢综合征中的关键因素
Antioxidants (Basel). 2025 Apr 3;14(4):434. doi: 10.3390/antiox14040434.
3
HDL-replacement therapy: From traditional to emerging clinical applications.
高密度脂蛋白替代疗法:从传统到新兴的临床应用
Atheroscler Plus. 2025 Feb 25;59:68-79. doi: 10.1016/j.athplu.2025.02.001. eCollection 2025 Mar.
4
Association of the Platelets to High Density Lipoprotein Cholesterol Ratio and Risk of Heart Disease Events in Middle-Aged and Elderly Chinese Population: A Retrospective Cohort Study Utilizing the CHARLS Database.中国中老年人群血小板与高密度脂蛋白胆固醇比值与心脏病事件风险的关联:一项利用中国健康与养老追踪调查(CHARLS)数据库的回顾性队列研究
Rev Cardiovasc Med. 2025 Feb 18;26(2):26403. doi: 10.31083/RCM26403. eCollection 2025 Feb.
5
Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.基于纳米载体的新兴基因治疗:心血管疾病的一种有前景的治疗选择及心脏瓣膜病的一种新策略
Int J Mol Sci. 2025 Feb 18;26(4):1743. doi: 10.3390/ijms26041743.
6
Molecular Mechanisms of Vascular Tone in Exercising Pediatric Populations: A Comprehensive Overview on Endothelial, Antioxidative, Metabolic and Lipoprotein Signaling Molecules.运动儿童群体中血管张力的分子机制:关于内皮、抗氧化、代谢和脂蛋白信号分子的全面概述
Int J Mol Sci. 2025 Jan 25;26(3):1027. doi: 10.3390/ijms26031027.
7
Association between lymphocyte to high-density lipoprotein cholesterol ratio and insulin resistance and metabolic syndrome in US adults: results from NHANES 2007-2018.美国成年人淋巴细胞与高密度脂蛋白胆固醇比值与胰岛素抵抗及代谢综合征之间的关联:2007 - 2018年美国国家健康与营养检查调查结果
Lipids Health Dis. 2025 Jan 10;24(1):9. doi: 10.1186/s12944-024-02411-7.
8
The Role of Scavenger Receptor BI in Sepsis.清道夫受体BI在脓毒症中的作用
Int J Mol Sci. 2024 Dec 15;25(24):13441. doi: 10.3390/ijms252413441.
9
An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis.氧化低密度脂蛋白诱导动脉粥样硬化中血管平滑肌细胞源性泡沫细胞的研究进展
Front Cell Dev Biol. 2024 Oct 25;12:1481505. doi: 10.3389/fcell.2024.1481505. eCollection 2024.
10
Serum lipid and lipoprotein profiles and their association with intraocular pressure in primary open-angle glaucoma: an observational cross-sectional study in the Chinese population.原发性开角型青光眼患者血清脂质和脂蛋白谱及其与眼压的关系:中国人的观察性横断面研究。
Lipids Health Dis. 2024 Sep 30;23(1):323. doi: 10.1186/s12944-024-02316-5.